Table 5

Cardiovascular hormones and hsTnT in myelodysplastic malignancies and solid tumours

Myelodysplastic malignancies (n=68)Solid tumours (n=388)p Value
hsTnT, ng/mL (IQR)0.006 (0.003–0.011)0.006 (0.003–0.011)0.962
NT-proBNP, pg/mL (IQR)153 (59–352)125 (66–268)0.520
MR-proANP, pmol/L (IQR)69.0 (50.1–117.6)62.4 (44.4–100.5)0.306
MR-proADM, nmol/L (IQR)0.61 (0.44–0.90)0.54 (0.43–0.72)0.129
CT-proET-1, pmol/L (IQR)50.1 (39.3–67.6)50.0 (39.4–66.1)0.797
Copeptin, pmol/L (IQR)4.8 (3.0–9.3)4.2 (2.7–7.9)0.226
  • Variables are displayed as median and IQR. Differences were calculated by the means of the Mann–Whitney U test.

  • CT-proET-1, C-terminal pro endothelin-1; hsTnT, high-sensitive troponin T; MR-proADM, mid-regional pro-adrenomedullin; MR-proANP, mid-regional pro-atrial natriuretic peptide; NT-proBNP, N-terminal pro B-type natriuretic peptide